Dry Eye Dx and Tx: Malfunctioning Mucins - Scorecard - MDSpire

Dry Eye Dx and Tx: Malfunctioning Mucins

Exploring the underappreciated role of mucins in dry eye disease reveals promising therapeutic avenues for improved management.

  • By

  • Roxanna Potter, OD

  • January 1, 2026

  • 4 min

Share

Clinical Scorecard: Dry Eye Dx and Tx: Malfunctioning Mucins

At a Glance

CategoryDetail
ConditionDry Eye Disease
Key MechanismsInvolves mucin dysfunction affecting tear film stability and ocular surface health.
Target PopulationIndividuals with dry eye disease, particularly those with mucin-related issues.
Care SettingOphthalmology clinics and primary care settings.

Key Highlights

  • Mucins are critical for tear film stability and ocular surface protection.
  • Mucin deficiency can lead to various ocular surface diseases.
  • Current treatment options for mucin-related issues are limited.
  • Compounded N-acetylcysteine (NAC) shows promise for mucin quality improvement.
  • Pharmaceutical advances are anticipated to enhance mucin therapy.

Guideline-Based Recommendations

Diagnosis

  • Assess mucin quality and quantity in patients with dry eye disease.

Management

  • Consider topical or oral secretagogues for mucin deficiency.

Monitoring & Follow-up

  • Evaluate ocular surface health and mucin characteristics regularly.

Risks

  • Oral secretagogues may cause systemic side effects.

Patient & Prescribing Data

Patients with dry eye disease experiencing mucin dysfunction.

Topical options for mucin enhancement are currently unavailable in the U.S.

Clinical Best Practices

  • Utilize NAC for its mucolytic and anti-inflammatory properties in mucin-related conditions.
  • Monitor for excessive mucin leading to corneal damage.

References

Original Source(s)

Dry Eye Dx and Tx: Malfunctioning Mucins

  • by Roxanna Potter, OD

  • January 1, 2026

Related Content

Ocular Surface Control: A Modern Approach to Peri-operative Dry Eye Management

Join us for a focused webinar exploring a modern approach to peri-operative dry eye management

  • April 22, 2026

  • 1 min
Driving Progress in Dry Eye Care

WCO and Alcon renew global dry eEye education partnership

  • February 5, 2026

  • 3 min
Optimizing the Ocular Surface Before and After Cataract Surgery

The role of perfluorohexyloctane in dry eye management